Prior Medications and the Cardiovascular Benefits From Combination Angiotensin‐Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High‐Risk Hypertensive Patients

BACKGROUND: The ACCOMPLISH (Avoiding Cardiovascular Events Through Combination Therapy in Patients Living with Systolic Hypertension) trial demonstrated that combination therapy using amlodipine, rather than hydrochlorothiazide, in conjunction with benazepril provided greater cardiovascular risk red...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Am Heart Assoc
Главные авторы: Brook, Robert D., Kaciroti, Niko, Bakris, George, Dahlöf, Björn, Pitt, Bertram, Velazquez, Eric, Weber, Michael, Zappe, Dion H., Hau, Tsushung, Jamerson, Kenneth A.
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2018
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5778960/
https://ncbi.nlm.nih.gov/pubmed/29301757
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.006940
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы